FDA Issues Warning for Type 2 Diabetes Drugs Including Canagliflozin, Dapagliflozin and Empagliflozin

A certain class of type 2 diabetes drugs can lead to a life-threatening condition called ketoacidosis, the U.S. Food and Drug Administration warns.

Read more

Posted in Drugs